Age dependent increase in prostaglandin pathway coincides with onset of ovarian cancer in laying hens

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 87, Issue 6, 2012, Pages 177-184

  Eilati, Erfan ^a   Pan, Lurui ^a   Bahr, Janice M ^b   Hales, Dale Buchanan ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Age; Cyclooxygenase; Inflammation; Laying hen; Ovarian cancer incidence; Prostaglandin E2

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PROSTAGLANDIN E2;

AGE DISTRIBUTION; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE LEVEL;

ADENOCARCINOMA; AGING; ANIMALS; ANIMALS, INBRED STRAINS; AVIAN PROTEINS; CHICKENS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME INDUCTION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; ILLINOIS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; OVARY; POULTRY DISEASES; PROSTAGLANDINS; RNA, MESSENGER; UP-REGULATION;

EID: 84870677710     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2012.09.003     Document Type: Article

References (55)

1. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357:539-545.
2. S.E. Erdman, T. Poutahidis, Cancer inflammation and regulatory T cells, Int. J. Cancer 127 (2010) 768-779.
3. Balkwill F., Coussens L.M. Cancer: an inflammatory link. Nature 2004, 431:405-406.
4. Allavena P., Garlanda C., Borrello M.G., Sica A., Mantovani A. Pathways connecting inflammation and cancer. Curr. Opin. Genet. Dev. 2008, 18:3-10.
5. Zeldin D.C. Epoxygenase pathways of arachidonic acid metabolism. J. Biol. Chem. 2001, 276:36059-36062.
6. Imig J.D., Hammock B.D. Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat. Rev. Drug Discovery 2009, 8:794-805.
7. Reese J., Zhao X., Ma W.G., Brown N., Maziasz T.J., Dey S.K. Comparative analysis of pharmacologic and/or genetic disruption of cyclooxygenase-1 and cyclooxygenase-2 function in female reproduction in mice. Endocrinology 2001, 142:3198-3206.
8. Dempke W., Rie C., Grothey A., Schmoll H.J. Cyclooxygenase-2: a novel target for cancer chemotherapy?. J. Cancer Res. Clin. Oncol. 2001, 127:411-417.
9. Greene E.R., Huang S., Serhan C.N., Panigrahy D. Regulation of inflammation in cancer by eicosanoids. Prostaglandins Other Lipid Mediators 2011, 96:27-36.
10. Williams C.S., Mann M., DuBois R.N. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999, 18:7908-7916.
11. Gupta R.A., Tejada L.V., Tong B.J., Das S.K., Morrow J.D., Dey S.K., DuBois R.N. Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer. Cancer Res. 2003, 63:906-911.
12. Daikoku T., Wang D., Tranguch S., Morrow J.D., Orsulic S., DuBois R.N., Dey S.K. Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer. Cancer Res. 2005, 65:3735-3744.
13. Takeshita E., Osanai T., Higuchi T., Soumaoro L.T., Sugihara K. Elevated cyclooxygenase-2 expression is associated with histological grade in invasive ductal breast carcinoma. J. Med. Dent. Sci. 2005, 52:189-193.
14. Wolff H., Saukkonen K., Anttila S., Karjalainen A., Vainio H., Ristimaki A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res. 1998, 58:4997-5001.
15. Denkert C., Kobel M., Pest S., Koch I., Berger S., Schwabe M., Siegert A., Reles A., Klosterhalfen B., Hauptmann S. Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma. Am. J. Pathol. 2002, 160:893-903.
16. Hales D.B., Zhuge Y., Lagman J.A., Ansenberger K., Mahon C., Barua A., Luborsky J.L., Bahr J.M. Cyclooxygenases expression and distribution in the normal ovary and their role in ovarian cancer in the domestic hen (Gallus domesticus). Endocrine 2008, 33:235-244.
17. Urick M.E., Johnson P.A. Cyclooxygenase 1 and 2 mRNA and protein expression in the Gallus domesticus model of ovarian cancer. Gynecol. Oncol. 2006, 103:673-678.
18. Vanderhyden B.C., Shaw T.J., Ethier J.F. Animal models of ovarian cancer. Reprod. Biol. Endocrinol. 2003, 1:67.
19. Yancik R., Ries L.G. Cancer in the aged. An epidemiologic perspective on treatment issues. Cancer 1991, 68:2502-2510.
20. Cramer D.W., Hutchison G.B., Welch W.R., Scully R.E., Ryan K.J. Determinants of ovarian cancer risk. I. Reproductive experiences and family history. J. Natl. Cancer Inst. 1983, 71:711-716.
21. Beltsos A.N., Odem R.R. Ovulation induction and ovarian malignancy. Semin. Reprod. Endocrinol. 1996, 14:367-374.
22. Crum C.P., Drapkin R., Miron A., Ince T.A., Muto M., Kindelberger D.W., Lee Y. The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr. Opin. Obstet. Gynecol. 2007, 19:3-9.
23. Kim J., Coffey D.M., Creighton C.J., Yu Z., Hawkins S.M., Matzuk M.M. High-grade serous ovarian cancer arises from fallopian tube in a mouse model. Proc. Natl. Acad. Sci. USA 2012, 109:3921-3926.
24. Cho K.R., Shih I.-M. Ovarian cancer. Ann. Rev. Pathol.: Mech. Dis. 2009, 4:287-313.
25. Kurman R.J., Shih Ie.M. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am. J. Surg. Pathol. 2010, 34:433-443.
26. Salvador S., Gilks B., Kobel M., Huntsman D., Rosen B., Miller D. The fallopian tube: primary site of most pelvic high-grade serous carcinomas. Int. J. Gynecol. Cancer 2009, 19:58-64.
27. Fathalla M.F. Incessant ovulation-a factor in ovarian neoplasia?. Lancet 1971, 2:163.
28. Landen C.N., Birrer M.J., Sood A.K. Early events in the pathogenesis of epithelial ovarian cancer. J. Clin. Oncol. 2008, 26:995-1005.
29. Zhuge Y., Lagman J.A., Ansenberger K., Mahon C.J., Daikoku T., Dey S.K., Bahr J.M., Hales D.B. CYP1B1 expression in ovarian cancer in the laying hen Gallus domesticus. Gynecol. Oncol. 2009, 112:171-178.
30. Ansenberger K., Zhuge Y., Lagman J.A., Richards C., Barua A., Bahr J.M., Hales D.B. E-cadherin expression in ovarian cancer in the laying hen, Gallus domesticus, compared to human ovarian cancer. Gynecol. Oncol. 2009, 113:362-369.
31. Barua A., Bitterman P., Abramowicz J.S., Dirks A.L., Bahr J.M., Hales D.B., Bradaric M.J., Edassery S.L., Rotmensch J., Luborsky J.L. Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer. Int. J. Gynecol. Cancer 2009, 19:531-539.
32. Ansenberger K., Richards C., Zhuge Y., Barua A., Bahr J.M., Luborsky J.L., Hales D.B. Decreased severity of ovarian cancer and increased survival in hens fed a flaxseed-enriched diet for 1 year. Gynecol. Oncol. 2010, 117:341-347.
33. Lynch M.J. Medical Laboratory Technology and Clinical Pathology. Saunders (W.B.) Co Ltd, 2nd Revised edition edition 1969.
34. Skeehan D.C., Hrapchak B.B. Theory and practice of histotechnology. Theory and Practice of Histotechnology 1973, Mosby, St. Louis, pp. 111-112.
35. Gosden R.G. The Biology of Menopause: The causes and consequences of ovarian aging 1985, Academic Press, New York.
36. R.A. Lobo, J. Kelsey, R. Marcus, Menopause: Biology and pathobiology, Academic press, 1st. Burlington, MA, 2000.
37. Smith E.R., Xu X.X. Ovarian ageing, follicle depletion, and cancer: a hypothesis for the aetiology of epithelial ovarian cancer involving follicle depletion. Lancet Oncol. 2008, 9:1108-1111.
38. Fredrickson T.N. Ovarian tumors of the hen. Environ. Health Perspect. 1987, 73:35-51.
39. Hayek M.G., Mura C., Wu D., Beharka A.A., Han S.N., Paulson K.E., Hwang D., Meydani S.N. Enhanced expression of inducible cyclooxygenase with age in murine macrophages. J. Immunol. 1997, 159:2445-2451.
40. Wilson T.W., McCaulay F.A., Waslen T.A. Effects of aging on responses to furosemide. Prostaglandins 1989, 38:675-687.
41. Vericel E., Croset M., Sedivy P., Courpron P., Dechavanne M., Lagarde M. Platelets and aging. I-Aggregation, arachidonate metabolism and antioxidant status. Thromb. Res. 1988, 49:331-342.
42. Martinez F.E., Reno C., Trevenen C.L., Hart D.A., Belik J. Age-dependent changes in the regulation of cyclooxygenases in the gastrointestinal tract after gram-negative endotoxemia. J. Pediatr. Gastroenterol. Nutr. 2001, 33:165-170.
43. Kino Y., Kojima F., Kiguchi K., Igarashi R., Ishizuka B., Kawai S. Prostaglandin E2 production in ovarian cancer cell lines is regulated by cyclooxygenase-1, not cyclooxygenase-2. Prostaglandins Leukotrienes Essent. Fatty Acids 2005, 73:103-111.
44. Jin Y., Zhang C., Zeng W., Taya K., Tan T.Q. Interactive actions of prostaglandin and epidermal growth factor to enhance proliferation of granulosa cells from chicken prehierarchical follicles. Prostaglandins Other Lipid Mediators 2007, 83:285-294.
45. Rosenstein M.M., Strausser H.R. Macrophage-induced T cell mitogen suppression with age. J. Reticuloendothel. Soc. 1980, 27:159-166.
46. Siironen P., Ristimaki A., Nordling S., Louhimo J., Haapiainen R., Haglund C. Expression of COX-2 is increased with age in papillary thyroid cancer. Histopathology 2004, 44:490-497.
47. Casolini P., Catalani A., Zuena A.R., Angelucci L. Inhibition of COX-2 reduces the age-dependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioral impairments in the rat. J. Neurosci. Res. 2002, 68:337-343.
48. Kushlinskii N.E., Podistov Iu.I., Laktionov K.P., Karseladze A.I., Babkina I.V., Kerimova G.I. Prostaglandins E in the primary tumor, metastases, and ascitic fluid of patients with ovarian cancer. Biull. Eksp. Biol. Med. 1997, 123:83-86.
49. Goodwin J.S., Ceuppens J. Regulation of the immune response by prostaglandins. J. Clin. Immunol. 1983, 3:295-315.
50. K. Brecht, A. Weigert, J. Hu, R. Popp, B. Fisslthaler, T. Korff, I. Fleming, G. Geisslinger, B. Brune, Macrophages programmed by apoptotic cells promote angiogenesis via prostaglandin E2, FASEB J. 25 (2011) 2408-2417.
51. Munkarah A.R., Morris R., Baumann P., Deppe G., Malone J., Diamond M.P., Saed G.M. Effects of prostaglandin E(2) on proliferation and apoptosis of epithelial ovarian cancer cells. J. Soc. Gynecol. Invest. 2002, 9:168-173.
52. Fischer S.M. Prostaglandins and cancer. Front Biosci. 1997, 2:d482-d500.
53. Sohal R.S., Orr W.C. Role of oxidative stress in senescence. Aging (Milano) 1998, 10:149-151.
54. Beharka A.A., Wu D., Serafini M., Meydani S.N. Mechanism of vitamin E inhibition of cyclooxygenase activity in macrophages from old mice: role of peroxynitrite. Free Radical Biol. Med. 2002, 32:503-511.
55. Feng L., Xia Y., Garcia G.E., Hwang D., Wilson C.B. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide. J. Clin. Invest. 1995, 95:1669-1675.